Status:
COMPLETED
HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention
Lead Sponsor:
Montefiore Medical Center
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Hepatitis C
Substance Use Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
People who inject drugs (PWID) represent the overwhelming majority of both HCV and HIV/HCV infected people in the United States. Though new, direct-acting HCV medications are highly efficacious and ha...
Detailed Description
The goal of this proposal is to improve HCV (hepatitis C virus) treatment uptake among current and former injection drug users (IDUs) by testing an innovative, primary care based HCV Group Evaluation ...
Eligibility Criteria
Inclusion
- HCV Ab+ with detectable HCV viral load
- greater than fifth grade reading level
- English proficiency
- current or former IDUs
- willingness to be randomized to a group intervention.
Exclusion
- short life-expectancy, such that HCV treatment would not be beneficial (e.g. end-stage cancer)
- decompensated liver disease
Key Trial Info
Start Date :
February 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT03242655
Start Date
February 21 2017
End Date
October 30 2020
Last Update
March 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comprehensive Health Care Center
The Bronx, New York, United States, 10451